European stocks finished higher on Wednesday after a bumper day of earnings, while investors awaited news from a two-day policy meeting of the U.S. Federal Reserve.» Read More
The Wall Street Journal has been analyzing the results of the European banking stress tests and wrote in a story published Tuesday that "some banks didn't provide as comprehensive a picture of their government-debt holdings as regulators claimed."
Banks and regulators agree more than they admit to publicly about new recommended capital requirements for G-20 nations, Barclays CEO Robert Diamond told CNBC Wednesday.
Big U.S. banks should be able to meet tighter global capital requirements without having to raise substantial amounts of new equity, according to calculations by Barclays Capital. The FT reports.
A federal judge on Tuesday criticized Barclays’ $298 million deal with the U.S. authorities to settle charges of facilitating payments that violated sanctions against countries including Cuba and Iran. The FT reports.
Barclays has agreed to pay $298 million over criminal allegations that it illegally engaged in financial transactions with banks in Cuba, Iran, Libya, Sudan and Burma, the Justice Department disclosed in court papers filed Monday.
A recent raid by one big New York law firm of a team of top acquisition finance lawyers from a rival firm may foreshadow a mergers and acquisitions boom.
The global nature of today's infrastructure has enabled European firms to make tremendous inroads. European banks might have it right this time, and here's why.
Think your BlackBerry or iPhone does everything already? Well it could do even more!
Three European banks have revealed capital-raising plans before the results of stress tests were due to be made public, the FT reports.
Are we looking at a wild ride on Friday afternoon? Results of European bank tests are due after Europe closes, but while we’re open!
The White House’s decision not to invite the chief executives of JP Morgan Chase and Goldman Sachs to today’s ceremonial signing of the financial overhaul legislation has many on Wall Street fuming.
Analysts have been more upbeat on company earnings. Investors don't share that sentiment. Here are the five companies whose share prices are most out of line with analysts' EPS upgrades over the past month.
Carlyle approached NBTY with an offer in early May, according to people familiar with the deal. NBTY moved to a limited auction, quickly after Carlyle jumped the process with a $55 a share offer. NBTY accepted, and has a 35 day go-shop.
Once again the traders are closely watching 1040 as a key level on the S&P. If the market closes above it, should you start buying?
Ignore the Street and listen to the markets. The price action in the stocks is telling you more than any research report.
If a certain Arkansas senator gets her way, you might want to consider buying a couple of European financials.
Britain’s competition regulator is opening a potentially damaging probe into the fees charged by investment banks on corporate share issues, ratcheting up the pressure on an already embattled industry.
The Qatar Investment Authority, a sovereign wealth fund, has expressed interest in buying part of the U.S. Treasury's stake in Citigroup, potentially boosting efforts to sell the shares amid the global rout in banking stocks, the FT reports citing people familiar with the matter .
Before his arrest on corruption charges, Wang Yi was not only a powerful financial official in the Communist party but also one of China’s most celebrated modern classical music composers. But since his detention and arrest last year, Mr Wang’s magnum opus – a symphony called Ode to China – has been dropped as a repertoire staple of the China National Symphony Orchestra and his compositions derided by formerly adoring media commentators and critics.
Stocks staged one of the most dramatic selloffs in market history Thursday as what may have been a trader error exacerbated losses in a market already jittery about the European debt crisis. The Dow ended down about 350 points and the VIX was above 34.